Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Action: Physiological Effects

Subinhibitory Concentrations of Protein Synthesis-Inhibiting Antibiotics Promote Increased Expression of the agr Virulence Regulator and Production of Phenol-Soluble Modulin Cytolysins in Community-Associated Methicillin-Resistant Staphylococcus aureus

Hwang-Soo Joo, June L. Chan, Gordon Y. C. Cheung, Michael Otto
Hwang-Soo Joo
Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
June L. Chan
Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon Y. C. Cheung
Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Otto
Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: motto@niaid.nih.gov
DOI: 10.1128/AAC.00064-10
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Tetracycline, clindamycin, and other protein synthesis inhibitors at subinhibitory concentrations significantly increased the expression of the pivotal virulence regulator agr and production of the agr-regulated cytolytic phenol-soluble modulins in the community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strain USA300. Our results suggest that such protein synthesis inhibitors may exacerbate the progression of CA-MRSA disease when applied at concentrations that are too low or when treating infections caused by strains resistant to those antibiotics.

Phenol-soluble modulins (PSMs) are key virulence factors of Staphylococcus aureus that lyse neutrophils and other cell types and elicit a series of proinflammatory responses (14). PSMs are produced by most S. aureus strains and contribute significantly to the progression of skin infection caused by epidemic community-associated methicillin-resistant S. aureus (CA-MRSA) (5, 14).

Subinhibitory concentrations of antibiotics may trigger differential expression of bacterial virulence determinants (4), which may lead to exacerbated disease, for example, when antibiotic regimes are not strictly followed by the patient. The effect of subinhibitory antibiotic concentrations on the expression of PSMs has not been investigated. Here, we analyzed PSM production under the influence of subinhibitory concentrations of several antibiotics in clinical use, focusing on antibiotics used for the treatment of hospital-associated MRSA (HA-MRSA) and CA-MRSA, including multidrug-resistant CA-MRSA (6) (Fig. 1 A and C). Of note, “subinhibitory” is often defined solely as having no effect on overnight growth. However, growth patterns may be severely affected even if strains reach comparable optical density values overnight; in that case, observed effects may simply be due to growth inhibition. Therefore, we ascertained that the used antibiotic concentrations did not cause considerable growth defects over the entire growth curve (Fig. 1B and D). As test strains, we chose the CA-MRSA strain USA300 (clone LAC), which is by far the most frequent cause of CA-MRSA infections in the United States (7, 11), and strain Sanger 252, representing a prevalent hospital-associated MRSA clone (9). To select optimal subinhibitory antibiotic concentrations (SICs) (Table 1), we first applied 1/10 of the published MICs. If under those conditions we found severe growth defects, SICs were gradually adjusted until only minimal effects on growth were observed. If no effect on PSM production was observed, we increased the SIC as much as possible without seeing a considerable growth defect. PSM concentrations were determined in triplicate by reversed-phase high-pressure chromatography/electrospray ionization mass spectrometry (RP-HPLC/ESI-MS) as described previously (14). One-way analysis of variances (ANOVAs) with Dunnett's multiple comparison tests were used to evaluate differences in PSM expression. Increased PSM levels were seen with tetracycline, clindamycin, erythromycin, and linezolid, and decreased levels were seen especially with oxacillin (Fig. 1A). In strain Sanger 252, changes in PSM levels were similar to those in strain LAC but in general less pronounced (Fig. 1C). However, in contrast to strain LAC, no significant change in PSM levels by oxacillin were observed, although oxacillin was applied at much higher concentrations for strain Sanger 252 (Table 1). Furthermore, there was decreased PSM production with mupirocin, which was not observed in strain LAC.

PSM peptides of S. aureus include the PSMα peptides (PSMα1, PSMα2, PSMα3, PSMα4), which are encoded in the psmα operon, the PSMβ peptides (PSMβ1, PSMβ2), which are encoded in the psmβ operon, and the δ-toxin, which is encoded within the region coding for RNAIII, the intracellular effector molecule of agr-mediated quorum sensing (12-14). PSMα peptides and δ-toxin are cytolytic, while PSMβ peptides lack that activity at physiological concentrations (14). In general, changes seen with antibiotics were most pronounced for PSMα1 and PSMα2. PSMα3 and PSMα4 were less affected, but the direction of changes was consistent with all PSMα peptides. Concentrations of the δ-toxin were not considerably affected, except for decreased production under the influence of oxacillin in strain LAC and mupirocin in strain Sanger 252. Concentrations of PSMβ peptides were very low and only PSMβ1 could be measured in most samples. Changes observed with PSMβ1 were overall consistent with those observed for PSMα peptides.

Expression of the psmα and psmβ operons is under strict and direct control of the agr quorum-sensing system (13-14). In addition, expression of the δ-toxin gene hld is directly linked to agr, as it is encoded within RNAIII (10). Overall, changes in PSM production under antibiotic influence were consistent among the different PSM peptides, suggesting that the various antibiotics may affect PSM production by an impact on agr activity. Thus, to evaluate whether agr contributes to the observed effects, we measured transcript levels of RNAIII, using those antibiotics for which the most pronounced changes in PSM levels were observed. In addition, we determined whether amounts of psmα and psmβ transcripts were affected, as can be expected in the case of an agr effect given the strong impact of agr on PSM expression (13-14). This experiment demonstrated that agr activity was significantly affected by clindamycin and tetracycline, and psmα and psmβ transcript levels changed accordingly. This suggests that an effect of agr is likely involved in the increased PSM production with those antibiotics, while the decreased production of PSMs under the influence of oxacillin did not appear to be mediated through agr (Fig. 2). In support of the former, agr activity is greater in strain LAC than in strain Sanger 252 (14), which is in accordance with the more pronounced changes in PSM production in LAC than in Sanger 252.

To our knowledge, these results demonstrate for the first time that subinhibitory concentrations of tetracycline and clindamycin have a strong stimulatory effect on the activity of agr. This represents an important finding, as agr controls a series of key virulence determinants of S. aureus, and tetracycline and clindamycin are frequently used for the treatment of MRSA infections. These infections may thus be severely exacerbated when using tetracycline or clindamycin at subinhibitory concentrations, such as when not following regimes or when dealing with strains that are resistant to those antibiotics. We are aware that our results contradict those achieved by Herbert et al., who reported that subinhibitory concentrations of clindamycin have no or a negative effect on agr expression (8). However, those authors used laboratory strains of S. aureus that may differ in many aspects from the clinical strains investigated herein.

Intriguingly, the antibiotics that caused increased activity of agr and production of PSMs work through the inhibition of protein synthesis by binding to the ribosome complex. In addition, although the treatment of a MRSA infection with oxacillin is certainly clinically wrong, the mechanism by which subinhibitory concentrations of oxacillin reduce PSM production in strain LAC is of great interest.

In conclusion, our study shows that the use of important antibiotics leads to increased expression of agr, PSMs, and possibly further virulence determinants and may thus exacerbate disease progression. This calls for rigid surveillance of regimes using these antibiotics and frequent susceptibility testing to avoid promoting virulence in bacterial strains resistant to those antibiotics.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Effects of antibiotics at subinhibitory concentrations on the production of PSMs. Different antibiotics, at the concentrations shown in Table 1, were added to cultures of S. aureus strains at the time of inoculation (1:100 from precultures) into 5-ml tubes filled with 1 ml of tryptic soy broth. Tubes were shaken for 24 h at 200 rpm, and PSM concentrations were determined in the culture filtrates using RP-HPLC/ESI-MS (14). Growth under the same conditions was monitored by determining the optical density at 600 nm (OD600). PSM concentrations in S. aureus LAC (USA300) (A), growth curves for S. aureus LAC (USA300) (B), PSM concentrations in S. aureus Sanger 252 (C), growth curves for S. aureus Sanger 252 (D). The parts of bars that are striped show the amount of N-deformylated (df) PSM among total PSM peptide concentration. Concentrations of PSMα1 are shown as an example of PSMα peptides. Statistical analysis is shown for the effects and antibiotics described in the text (Er, Te, Cl, Lin for both strains, Ox for LAC, and Mu for Sanger 252); **, P < 0.01; ***, P < 0.001; con, control (without antibiotic). Error bars represent means ± standard deviations.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Activity of agr in comparison to psmα and psmβ transcript levels under the influence of subinhibitory concentrations of tetracycline, clindamycin, and oxacillin. The activity of agr was determined by real-time quantitative reverse transcription-PCR (qRT-PCR) of RNAIII in strain LAC (USA300). The expression of psm operons was determined by qRT-PCR of psmα and psmβ transcripts under the same conditions (after 8 h of growth in shaken 125-ml flasks). Primers and conditions for qRT-PCR were as described, using the gyrB transcript as a control (13-14). Experiments were performed in triplicate. Error bars represent means ± standard deviations. The antibiotic concentrations used are shown in Table 1. **, P < 0.01; ***, P < 0.001.

View this table:
  • View inline
  • View popup
TABLE 1.

Subinhibitory concentrations of antibiotics used in this studya

ACKNOWLEDGMENTS

This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH).

FOOTNOTES

    • Received 16 January 2010.
    • Returned for modification 2 April 2010.
    • Accepted 6 August 2010.
  • Copyright © 2010 American Society for Microbiology

REFERENCES

  1. 1.
    Bismuth, R., R. Zilhao, H. Sakamoto, J. L. Guesdon, and P. Courvalin. 1990. Gene heterogeneity for tetracycline resistance in Staphylococcus spp. Antimicrob. Agents Chemother.34:1611-1614.
    OpenUrlAbstract/FREE Full Text
  2. 2.
    Credito, K., G. Lin, and P. C. Appelbaum. 2007. Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology. Antimicrob. Agents Chemother.51:1504-1507.
    OpenUrlAbstract/FREE Full Text
  3. 3.
    Critchley, I. A., C. L. Young, K. C. Stone, U. A. Ochsner, J. Guiles, T. Tarasow, and N. Janjic. 2005. Antibacterial activity of REP8839, a new antibiotic for topical use. Antimicrob. Agents Chemother.49:4247-4252.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Davies, J., G. B. Spiegelman, and G. Yim. 2006. The world of subinhibitory antibiotic concentrations. Curr. Opin. Microbiol.9:445-453.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    DeLeo, F. R., M. Otto, B. N. Kreiswirth, and H. F. Chambers. 2010. Community-associated methicillin-resistant Staphylococcus aureus. Lancet375:1557-1568.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Diep, B. A., H. F. Chambers, C. J. Graber, J. D. Szumowski, L. G. Miller, L. L. Han, J. H. Chen, F. Lin, J. Lin, T. Haivan Phan, H. A. Carleton, L. K. McDougal, F. C. Tenover, D. E. Cohen, K. H. Mayer, G. F. Sensabaugh, and F. Perdreau-Remington. 2008. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann. Intern. Med.148:249-257.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Diep, B. A., S. R. Gill, R. F. Chang, T. H. Phan, J. H. Chen, M. G. Davidson, F. Lin, J. Lin, H. A. Carleton, E. F. Mongodin, G. F. Sensabaugh, and F. Perdreau-Remington. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet367:731-739.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Herbert, S., P. Barry, and R. P. Novick. 2001. Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect. Immun.69:2996-3003.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Holden, M. T., E. J. Feil, J. A. Lindsay, S. J. Peacock, N. P. Day, M. C. Enright, T. J. Foster, C. E. Moore, L. Hurst, R. Atkin, A. Barron, N. Bason, S. D. Bentley, C. Chillingworth, T. Chillingworth, C. Churcher, L. Clark, C. Corton, A. Cronin, J. Doggett, L. Dowd, T. Feltwell, Z. Hance, B. Harris, H. Hauser, S. Holroyd, K. Jagels, K. D. James, N. Lennard, A. Line, R. Mayes, S. Moule, K. Mungall, D. Ormond, M. A. Quail, E. Rabbinowitsch, K. Rutherford, M. Sanders, S. Sharp, M. Simmonds, K. Stevens, S. Whitehead, B. G. Barrell, B. G. Spratt, and J. Parkhill. 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U. S. A.101:9786-9791.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Janzon, L., S. Lofdahl, and S. Arvidson. 1989. Identification and nucleotide sequence of the delta-lysin gene, hld, adjacent to the accessory gene regulator (agr) of Staphylococcus aureus. Mol. Gen. Genet.219:480-485.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    Moran, G. J., A. Krishnadasan, R. J. Gorwitz, G. E. Fosheim, L. K. McDougal, R. B. Carey, and D. A. Talan. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med.355:666-674.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Novick, R. P., H. F. Ross, S. J. Projan, J. Kornblum, B. Kreiswirth, and S. Moghazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J.12:3967-3975.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Queck, S. Y., M. Jameson-Lee, A. E. Villaruz, T. H. Bach, B. A. Khan, D. E. Sturdevant, S. M. Ricklefs, M. Li, and M. Otto. 2008. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell32:150-158.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Wang, R., K. R. Braughton, D. Kretschmer, T. H. Bach, S. Y. Queck, M. Li, A. D. Kennedy, D. W. Dorward, S. J. Klebanoff, A. Peschel, F. R. DeLeo, and M. Otto. 2007. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med.13:1510-1514.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Subinhibitory Concentrations of Protein Synthesis-Inhibiting Antibiotics Promote Increased Expression of the agr Virulence Regulator and Production of Phenol-Soluble Modulin Cytolysins in Community-Associated Methicillin-Resistant Staphylococcus aureus
Hwang-Soo Joo, June L. Chan, Gordon Y. C. Cheung, Michael Otto
Antimicrobial Agents and Chemotherapy Oct 2010, 54 (11) 4942-4944; DOI: 10.1128/AAC.00064-10

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Subinhibitory Concentrations of Protein Synthesis-Inhibiting Antibiotics Promote Increased Expression of the agr Virulence Regulator and Production of Phenol-Soluble Modulin Cytolysins in Community-Associated Methicillin-Resistant Staphylococcus aureus
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Subinhibitory Concentrations of Protein Synthesis-Inhibiting Antibiotics Promote Increased Expression of the agr Virulence Regulator and Production of Phenol-Soluble Modulin Cytolysins in Community-Associated Methicillin-Resistant Staphylococcus aureus
Hwang-Soo Joo, June L. Chan, Gordon Y. C. Cheung, Michael Otto
Antimicrobial Agents and Chemotherapy Oct 2010, 54 (11) 4942-4944; DOI: 10.1128/AAC.00064-10
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
Bacterial Proteins
Bacterial Toxins
Cytotoxins
methicillin-resistant Staphylococcus aureus
Protein Synthesis Inhibitors
Trans-Activators

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596